ArticleMalaria journal2024
Physical and insecticidal durability of Interceptor
Article in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The attrition, physical and insecticidal durability of two dual active ingredient nets (Interceptor® G2 and Royal Guard®) in Benin, West Africa: results from a durability study embedded in a cluster randomised controlled trial.Parasites & vectors · 2024Trial
- Modelling the impact of adopting new-generation insecticide-treated nets on malaria transmission and insecticide resistance.Parasites & vectors · 2026Article
- Reductions in malaria cases after deployment of dual-active ingredient insecticide-treated nets in Ghana-a Bayesian interrupted time series analysis.International journal of epidemiology · 2026Article
- Residual efficacy of standard and new-generation long-lasting insecticidal nets 3 years after mass distribution in Côte d'Ivoire.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026Article
- Costs of single-phase door-to-door insecticide-treated net mass distribution campaigns in Nigeria: a case study in Ondo and Anambra states.Malaria journal · 2026Article
- Redefining the Wash Resistance Index to predict insecticidal durability of mosquito nets.MalariaWorld journal · 2026Article
- Three-year trends in malaria transmission parameters under deployment of Interceptor®G1, Interceptor®G2 and PermaNet®3.0 insecticide-treated bed nets in South-Western Burkina Faso.Malaria journal · 2025Article
- Fabric integrity, net type and risk index predict attrition of insecticide-treated nets: evidence from a community durability trial of pyrethroid-piperonyl butoxide (PBO) nets in Tanzania.Malaria journal · 2025Review
- Physical and insecticidal durability of PermaNetMalaria journal · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNational Malaria Programmes (NMPs) monitor the durability of insecticide-treated nets (ITNs) to inform procurement and replacement decisions. This is crucial for new dual active ingredients (AI) ITNs, for which less data is available. Pyrethroid-only ITN (Interceptor
methodsDurability was monitored through a prospective study of a cohort of nets distributed during the 2019 mass campaign. Three health districts were selected for their similar pyrethroid-resistance, environmental, epidemiological, and population profiles. Households were recruited after the mass campaign, with annual household questionnaire follow-ups over three years. Each round, ITNs were withdrawn for bioassays and chemical residue testing. Key measures were the percentage of cohort ITNs in serviceable condition, insecticidal effectiveness, and chemical residue content against target dose. Cox proportional hazard models were used to identify determinants influencing ITN survival.
resultsAt endline, the median useful life was 3.2 (95% CI 2.5-4.0) years for PermaNet
conclusionOnly PermaNet
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.